Nancy Bartlett, Hongli Li, Michael Knopp, Chad Wright, Heiko Schoder, Lawrence Schwartz, Sharon Castellino, Sarah Rutherford, Andrew Evens, Kelly Davison, Angela Punnett, Margaret Shipp, Brad Kahl, John Leonard, Sonali Smith, Joo Song, Lale Kostakoglu, Kara Kelly, Michael LeBlanc, Jonathan Friedberg, Alex Herrera. "Interim and end-of-treatment FDG-PET demonstrate limited ability to predict 3-year progression-free survival with nivolumab-AVD in first-line treatment of advanced stage Hodgkin lymphoma: Imaging sub-analysis of Phase 3 S1826 study." Blood, 2025. doi:10.1182/blood-2025-1851